DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Anderson R, Adamson D, Yellowlees A et al.
GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the OPTION trial. Anglo Celtic Collaborative Oncology Group and NCRI trialists P 488, ESHRE, Helsinki, 2016, Abstractbook i339.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.